secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0000064803-24-000019
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS shareholders approve 33.5M share increase to equity plan; all directors elected
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2017 ICP, increasing authorized shares by 33.5 million for future awards.
- All 12 director nominees elected, including CEO Karen S. Lynch, with >85% support from votes cast.
- Advisory vote on named executive officer compensation passed (818M for, 139M against, excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for 2024 approved (1.083B for, 22.9M against).
- Four stockholder proposals (worker rights, majority vote, golden parachute, director time disclosure) all rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000019/0000064803-24-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000019/cvs-20240516.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer